Most read articles

  • HOME
  • BROWSE ARTICLES
  • Most read articles

From articles published in J Urol Oncol during the past two years (2023~ ).

Review Article
532
Complex Epidemiology of Prostate Cancer in Asian Countries   (5,095 times)
Kagenori Ito, Takahiro Kimura
Journal of Urologic Oncology. 2023;21(1):5-13.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
533
Current Update on Prostate Cancer Immunotherapy   (3,523 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
Journal of Urologic Oncology. 2023;21(1):14-22.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
The Landscape of Epidemiology in Urologic Cancers
Original Article
535
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades   (3,207 times)
Sang Heon Han, Hyeong Dong Yuk
Journal of Urologic Oncology. 2023;21(1):32-44.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Original Article
539
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up   (3,105 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, Jongsoo Lee, Won Sik Jang, Nam Hoon Cho, Young Deuk Choi
Journal of Urologic Oncology. 2023;21(1):70-78.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Bladder Cancer
Systemic Review and Meta-analysis
565
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients   (3,008 times)
Stefani Frost, Parisa Ziarati, Ryan Moen, Lynn Kysh, Robert Johnson, Shane Pearce, Siamak Daneshmand, Kimberly D. Siegmund, Victoria K. Cortessis
Journal of Urologic Oncology. 2024;22(1):78-94.   Published online March 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Invited Review
557
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023   (3,001 times)
Jiwoong Yu, Hyun Hwan Sung
Journal of Urologic Oncology. 2023;21(3):228-240.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
534
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies   (2,968 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, Takayuki Goto, Takashi Kobayashi
Journal of Urologic Oncology. 2023;21(1):23-31.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Invited Review
551
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer   (2,918 times)
Hyunho Han, Minyong Kang, Seok-Soo Byun, Seok Joong Yun
Journal of Urologic Oncology. 2023;21(2):128-139.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
540
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy   (2,794 times)
Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, Seok Ho Kang, Seung Il Jung, Jin Sung Park, Ho Kyung Seo, Hyung Joon Kim, Byong Chang Jeong, Tae-Hwan Kim, Se Young Choi, Jong Kil Nam, Ja Yoon Ku, Kwan Joong Joo, Won Sik Jang, Young Eun Yoon, Seok Joong Yun, Sung-Hoo Hong, Jong Jin Oh
Journal of Urologic Oncology. 2023;21(1):79-87.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Original Article
549
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis   (2,756 times)
Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham
Journal of Urologic Oncology. 2023;21(2):165-173.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Invited Review
556
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type   (2,585 times)
Chan Woo Wee, Jaeho Cho
Journal of Urologic Oncology. 2023;21(3):217-227.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Invited Review
545
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials   (2,522 times)
Sang Hun Song, Jong Jin Oh
Journal of Urologic Oncology. 2023;21(2):154-164.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey   (2,409 times)
Joongwon Choi, Cheryn Song, Jungyo Suh, Minyong Kang, Chang Il Choi, Hyeong Dong Yuk, Chan Ho Lee, Jung Kwon Kim, Jung Ki Jo, Won Sik Ham, Eu Chang Hwang, Chang Wook Jeong, Young Hwii Ko, Jae Young Park, Seong Il Seo, Byung Kwan Park, Jinsoo Chung, Cheol Kwak, Sung-Hoo Hong
Journal of Urologic Oncology. 2023;21(1):59-69.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
536
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database   (2,390 times)
Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, Woo Suk Choi, Yun-Sok Ha, Jeong Hyun Kim, Cheol Kwak
Journal of Urologic Oncology. 2023;21(1):45-52.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Invited Review
544
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance   (2,378 times)
Chang Wook Jeong
Journal of Urologic Oncology. 2023;21(2):97-105.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Invited Review
550
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use   (2,363 times)
Byung Kwan Park
Journal of Urologic Oncology. 2023;21(2):106-111.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Editorial
Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2   (2,292 times)
Cheol Kwak
Journal of Urologic Oncology. 2024;22(2):97-99.   Published online July 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Prostate Cancer
Invited Review
569
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review   (2,209 times)
Chang Wook Jeong
Journal of Urologic Oncology. 2024;22(1):4-10.   Published online March 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Invited Review
543
Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?   (2,167 times)
Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, Eu Chang Hwang, Mi Ah Han, Jae Hung Jung, Hunju Lee, Myung Ha Kim, Cheol Kwak, Sun Il Kim, for the Korean Urologic Oncology Society Guideline Development Committee, Korean Renal Cancer Study Group
Journal of Urologic Oncology. 2023;21(2):140-147.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Invited Review
553
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma   (2,147 times)
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master
Journal of Urologic Oncology. 2023;21(3):183-199.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI